Where does Allena Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Allena Pharmaceuticals, Inc. ranks #30,795 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Allena Pharmaceuticals, Inc. hold?

Allena Pharmaceuticals, Inc. holds 8 US utility patents granted between 2017 and 2021, spanning 10 technology areas.

What is Allena Pharmaceuticals, Inc.'s Innovation Score?

Allena Pharmaceuticals, Inc. has an Innovation Score of 28.9 out of 100 (29th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Allena Pharmaceuticals, Inc. focus on?

Allena Pharmaceuticals, Inc.'s top technology area is C12Y (Enzymes) with 8 patents, ranking #343 of 1,675 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Allena Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Allena Pharmaceuticals, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Allena Pharmaceuticals, Inc.'s patents?

Allena Pharmaceuticals, Inc.'s patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Allena Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Allena Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Y (Enzymes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Allena ranks #30,795 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 10 technology areas.

#30,795
of 49,997 US assignees by volume: 29th percentile
by Innovation Score (28.9/100): 16.9
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30795 · US Corporation #30,795 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #30,795/49,997
PHOTO-FINISH Algoblu Holdings
CPC-FOCUS C12Y · 10 areas
INNOV-THIN 28.9/100
CLAIMS-RICH 16.9 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Algoblu Holdings Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Allena’s 28.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (26%) Velocity 0.0 pts (0%) Breadth 11.2 pts (39%) Claim depth 10.1 pts (35%)

Qualcomm Incorporated · highest

85
Allena Pharmaceuticals · this assignee

29
3D Lighting… · lowest

7

What this shows Allena's Innovation Score is 28.9/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Allena?

Each dot is one of Allena’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Allena’s own 16.9 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Allena vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Allena's grants concentrate

Allena Pharmaceuticals, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under C12Y (Enzymes). By volume, Allena sits between Algoblu Holdings Limited and Alzchem Trostberg GmbH.

Algoblu Holdings

8
Alienvault

8
Alimetry

8
Allegro Pharmaceu…

8
Allied Mineral Pr…

8
Altavant Sciences

8
Altratech

8
Alzchem Trostberg

8
Allena Pharmaceut… ◀

8

What this shows Allena holds 8 patents at rank #30,880, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Allena

By rank, the assignees closest to #30,880 in granted patent volume.

Leaders in C12Y (Enzymes)

Other assignees with the most granted patents in Allena's primary technology class.

Allena's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Allena Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	25.0%
2019	2	25.0%
2020	2	25.0%
2021	2	25.0%

Which technologies does Allena Pharmaceuticals, Inc. patent most?

C12Y - Enzymes 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C07K - Peptides 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Allena Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Allena Pharmaceuticals, Inc.'s lead technology class is C12Y (Enzymes), 100% of its portfolio - see every assignee active in that class. Explore C12Y
Ranked #30,795 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Allena Pharmaceuticals, Inc. against Algoblu Holdings Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.